PlainRecalls
FDA Drug Critical Class I Terminated

fentaNYL citrate in 0.9% Sodium Chloride Injection, 10 mcg/1 mL (10 mcg/mL), in 1 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-024-45, UPC: 0100352533024450

Reported: July 13, 2016 Initiated: August 21, 2015 #D-1152-2016

Product Description

fentaNYL citrate in 0.9% Sodium Chloride Injection, 10 mcg/1 mL (10 mcg/mL), in 1 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-024-45, UPC: 0100352533024450

Reason for Recall

Subpotent Drug

Details

Recalling Firm
Cantrell Drug Company
Units Affected
884 syringes
Distribution
Nationwide
Location
Little Rock, AR

Frequently Asked Questions

What product was recalled?
fentaNYL citrate in 0.9% Sodium Chloride Injection, 10 mcg/1 mL (10 mcg/mL), in 1 mL Syringe, Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-024-45, UPC: 0100352533024450. Recalled by Cantrell Drug Company. Units affected: 884 syringes.
Why was this product recalled?
Subpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on July 13, 2016. Severity: Critical. Recall number: D-1152-2016.